The global dissemination of the novel coronavirus disease (COVID-19) has accelerated the need for the implementation of effective antimicrobial strategies to target the causative agent SARS-CoV-2. Light-based technologies have a demonstrable broad range of activity over standard chemotherapeutic antimicrobials and conventional disinfectants, negligible emergence of resistance, and the capability to modulate the host immune response. This perspective article identifies the benefits, challenges, and pitfalls of repurposing light-based strategies to combat the emergence of COVID-19 pandemic. Highlights • Light-based technologies currently are cost-effective and widely available in market. • Photons can be used to inactivate SARS-CoV-2 in air, liquids and on surfaces. • Phototherapy can be used as an adjuvant to control virus infection and to modulate host immune system. • Light-based solutions can significantly contribute to mitigate the impacts of COVID-19 pandemic
【저자키워드】 ultraviolet, Photobiomodulation, Photoinactivation, virucidal, germicidal, photodynamic, photobiology,